Your browser doesn't support javascript.
loading
Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort study.
van den Elsen, Simone Hj; Sturkenboom, Marieke Gg; Akkerman, Onno; Barkane, Linda; Bruchfeld, Judith; Eather, Geoffrey; Heysell, Scott K; Hurevich, Henadz; Kuksa, Liga; Kunst, Heinke; Kuhlin, Johanna; Manika, Katerina; Moschos, Charalampos; Mpagama, Stellah G; Muñoz Torrico, Marcela; Skrahina, Alena; Sotgiu, Giovanni; Tadolini, Marina; Tiberi, Simon; Volpato, Francesca; van der Werf, Tjip S; Wilson, Malcolm R; Zúñiga, Joaquin; Touw, Daan J; Migliori, Giovanni B; Alffenaar, Jan-Willem.
Affiliation
  • van den Elsen SH; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Sturkenboom MG; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Akkerman O; Department of Pulmonary Diseases and Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Barkane L; Tuberculosis Center Beatrixoord, University of Groningen, University Medical Center Groningen, Haren, The Netherlands.
  • Bruchfeld J; Department of Multidrug Resistant Tuberculosis, Riga East University Hospital TB and Lung Disease Clinic, Riga, Latvia.
  • Eather G; Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
  • Heysell SK; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Hurevich H; Department of Respiratory Medicine and Metro South Clinical Tuberculosis Service, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.
  • Kuksa L; Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA.
  • Kunst H; The Republican Scientific and Practical Center for Pulmonology and Tuberculosis, Minsk, Belarus.
  • Kuhlin J; Department of Multidrug Resistant Tuberculosis, Riga East University Hospital TB and Lung Disease Clinic, Riga, Latvia.
  • Manika K; Department of Respiratory Medicine, Blizard Institute, Queen Mary University of London, Barts Health NHS Trust, London, UK.
  • Moschos C; Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
  • Mpagama SG; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Muñoz Torrico M; Pulmonary Department, Respiratory Infections Unit, G. Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Skrahina A; Drug-Resistant Tuberculosis Unit, 'Sotiria' Hospital for Chest Diseases, Athens, Greece.
  • Sotgiu G; Kibong'oto Infectious Diseases Hospital, Kilimanjaro, United Republic of Tanzania.
  • Tadolini M; Clínica de Tuberculosis, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico.
  • Tiberi S; The Republican Scientific and Practical Center for Pulmonology and Tuberculosis, Minsk, Belarus.
  • Volpato F; Department of Medical, Surgical and Experimental Sciences, Clinical Epidemiology and Medical Statistics Unit, University of Sassari, Sassari, Italy.
  • van der Werf TS; Department of Medical and Surgical Sciences, Unit of Infectious Diseases, Alma Mater Studiorum University of Bologna, Bologna, Italy.
  • Wilson MR; Department of Infection, Blizard Institute, Queen Mary University of London, Barts Health NHS Trust, London, UK.
  • Zúñiga J; Department of Medical and Surgical Sciences, Unit of Infectious Diseases, Alma Mater Studiorum University of Bologna, Bologna, Italy.
  • Touw DJ; Department of Pulmonary Diseases and Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Migliori GB; Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Alffenaar JW; Department of Respiratory Medicine and Metro South Clinical Tuberculosis Service, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.
BMJ Open ; 10(6): e035350, 2020 06 16.
Article in En | MEDLINE | ID: mdl-32554740
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Monitoring / Tuberculosis, Multidrug-Resistant / Fluoroquinolones / Anti-Bacterial Agents Type of study: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Ethics Limits: Humans Language: En Journal: BMJ Open Year: 2020 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Monitoring / Tuberculosis, Multidrug-Resistant / Fluoroquinolones / Anti-Bacterial Agents Type of study: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Ethics Limits: Humans Language: En Journal: BMJ Open Year: 2020 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom